Baudax Bio Inc. (BXRX)
NASDAQ: BXRX
· Real-Time Price · USD
0.02
-0.00 (-1.48%)
At close: Feb 29, 2024, 9:53 PM
Baudax Bio Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.38 | -0.19 | 0.09 | -0.14 | -0.02 | -0.2 | -0.22 | 0.16 | -0.7 | -0.93 | -1.19 |
PEG Ratio | 0.00 | 0.00 | -0.00 | 0.00 | -0.00 | 0.00 | 0.00 | -0.00 | 0.36 | 0.04 | 0.05 |
PS Ratio | n/a | 190.52 | -281.54 | 16.66 | 12.23 | 20.23 | 26.90 | 46.40 | 169.40 | 283.20 | 407.74 |
PB Ratio | -0.29 | -0.54 | -0.54 | -0.21 | -0.15 | 1.43 | 1.17 | 1.40 | -2.3 | -12.45 | -81.22 |
P/FCF Ratio | -1.23 | -1.66 | -0.85 | -1.38 | -0.75 | -0.84 | -0.88 | -1.45 | -3.79 | -5.66 | -5.73 |
P/OCF Ratio | -1.23 | -1.66 | -0.85 | -1.37 | -0.75 | -0.84 | -0.88 | -1.47 | -3.79 | -5.66 | -5.76 |
OCF/S Ratio | n/a | -114.87 | 333.14 | -12.2 | -16.34 | -24.06 | -30.58 | -31.61 | -44.73 | -50 | -70.73 |
Debt / Equity Ratio | -0.79 | -0.82 | -1.02 | -0.29 | -0.41 | 2.06 | 0.90 | 0.65 | -0.4 | -1.77 | -9.44 |
Quick Ratio | 0.07 | 0.09 | 0.33 | 0.30 | 0.32 | 0.40 | 0.71 | 1.18 | 1.86 | 2.87 | 2.90 |
Current Ratio | 0.07 | 0.09 | 0.33 | 0.30 | 0.53 | 0.69 | 0.97 | 1.50 | 2.16 | 3.13 | 3.09 |
Asset Turnover | n/a | 0.00 | -0.00 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
Interest Coverage | n/a | n/a | 0.29 | -9.34 | 0.37 | -2.63 | 1.65 | 51.83 | n/a | n/a | -27.66 |
Return on Equity | 0.19 | 0.69 | -1.56 | 0.38 | 1.49 | -1.78 | -1.31 | 2.23 | 0.82 | 3.35 | 17.01 |
Return on Assets | -0.09 | -0.35 | 1.61 | -0.92 | -1.67 | -0.18 | -0.26 | 0.55 | -0.28 | -0.21 | -0.23 |
Return on Invested Capital | 0.90 | 5.25 | -40.16 | 0.59 | -1.47 | -0.58 | -0.69 | 1.51 | 1.62 | -5.82 | -2.01 |
Dividend Yield | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | -2.47 | 29.93 | -14.46 | -4.08 | -0.2 | -0.54 | -0.44 | -0.64 | -1.92 | -3.15 |
Net Profit Margin | n/a | -245.83 | -814.57 | -29.84 | -122.71 | -25.1 | -30.35 | 73.58 | -60.36 | -76.26 | -85.41 |
Pretax Profit Margin | n/a | -243.37 | 527.57 | -29.84 | -122.71 | -25.1 | -30.35 | 73.58 | -60.36 | -76.26 | -85.41 |
Operating Profit Margin | n/a | -234.83 | 334.86 | -27.74 | 69.59 | -23.24 | -29.73 | 75.03 | -58.29 | -81.17 | -82.43 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -2.47 | 334.64 | -21.58 | -25.33 | -12.54 | -37.23 | -7.27 | -58.29 | -81.17 | -82.43 |